NCERT grounding
NCERT Class XII Biology, Chapter 7 (Human Health and Disease), Section 7.2.6, places auto-immunity inside the larger discussion of acquired immunity. The text is brief but every clause has been mined for PYQs. NCERT first reminds us that memory-based acquired immunity in higher vertebrates rests on the ability to distinguish foreign organisms (pathogens) from self-cells. It then notes two corollaries: higher vertebrates also distinguish foreign molecules, and — critically — that "sometimes, due to genetic and other unknown reasons, the body attacks self-cells", producing what NCERT calls auto-immune disease. NCERT explicitly names rheumatoid arthritis as a prevalent example and, in Section 7.2.7, lists auto-immune disease alongside allergy and organ-transplant rejection as the three abnormal contexts in which the immune system plays a central role.
"Sometimes, due to genetic and other unknown reasons, the body attacks self-cells. This results in damage to the body and is called auto-immune disease. Rheumatoid arthritis… is an auto-immune disease."
NCERT XII Biology, Section 7.2.6
NIOS Biology, Chapter 31 (Immunobiology — An Introduction), reinforces the same operating definition: the immune system identifies anything "foreign to itself" and acts to neutralize, eliminate or metabolize the foreign entity. Auto-immunity is therefore not a failure of strength but a failure of identification — the same effector machinery, pointed in the wrong direction. For NEET purposes, the entire NCERT passage above is in scope and is the textual seed for nearly every question we will see in the snapshot below.
Auto-immunity — mechanism and disease spectrum
Self/non-self discrimination — the property that fails
The vertebrate adaptive immune system carries roughly 1011 T- and B-lymphocyte clones, each bearing a unique antigen receptor. During lymphocyte development, clones whose receptors bind strongly to self-antigens are deleted (central tolerance in thymus and bone marrow) or anergised in the periphery (peripheral tolerance). The surviving repertoire is, in principle, blind to self and reactive only to non-self. Auto-immunity is the breakdown of this filter: a self-reactive clone escapes deletion, is activated, expands, and directs antibodies or cytotoxic T-cells against the patient's own tissues.
NCERT keeps the cause deliberately vague — "genetic and other unknown reasons" — and NEET keys directly off that wording. The two best-validated triggers are HLA-linked genetic susceptibility (certain MHC alleles present self-peptides in a more inflammatory way) and molecular mimicry, in which a microbial epitope so closely resembles a self-epitope that a normal anti-pathogen response cross-reacts with host tissue. Both end in the same place: a self-antigen is treated as foreign.
From normal tolerance to auto-immune damage
-
Step 1
Self-tolerance established
Self-reactive T/B-cells are deleted in thymus and bone marrow; surviving clones target only non-self antigens.
-
Step 2
Loss of tolerance
Genetic predisposition, infection-driven molecular mimicry or release of hidden self-antigens lets a self-reactive clone escape.
-
Step 3
Activation & expansion
The escaped clone is activated by APCs, proliferates, and produces auto-antibodies or cytotoxic effector T-cells against a self-antigen.
-
Step 4
Tissue damage
Chronic attack on the target tissue (joint synovium, neuromuscular junction, β-cells, myelin) produces the clinical auto-immune disease.
The named NCERT example — rheumatoid arthritis
Rheumatoid arthritis (RA) is the only auto-immune disease that NCERT names in the chapter, which makes it the most testable. In RA, auto-antibodies (including rheumatoid factor and anti-citrullinated peptide antibodies) and self-reactive T-cells target the synovial membrane lining mobile joints. The synovium becomes inflamed, thickens into a pannus, and gradually erodes the underlying articular cartilage and bone. Joints — typically the small joints of the hands and feet, symmetrically — become swollen, stiff (worst in the morning) and progressively deformed. RA is the canonical NCERT auto-immune disease and the option-key for the 2022 statement-pair PYQ in our snapshot.
Figure 1. In rheumatoid arthritis the immune system fails self/non-self discrimination and attacks the synovial membrane of joints. Chronic inflammation produces a thickened pannus that erodes cartilage and bone, narrowing the joint space.
Myasthenia gravis — antibodies against acetylcholine receptors
Myasthenia gravis (MG) is a chronic auto-immune disorder in which auto-antibodies are produced against nicotinic acetylcholine receptors (AChR) on the post-synaptic membrane of the neuromuscular junction. Each motor nerve impulse releases acetylcholine into the synaptic cleft, but the antibodies block, cross-link and accelerate internalisation of the receptors. With fewer functional receptors, end-plate potentials fail to reach threshold, the muscle fibre fails to contract, and the patient experiences fatigability, drooping eyelids (ptosis), double vision and progressive weakness of skeletal muscle. NEET 2021 and 2022 both probed this disease as a one-mark MCQ — once asking for the disease name from the description, once trapping students by pairing it with the wrong descriptor.
Myasthenia gravis is auto-immune, not genetic; muscular dystrophy is genetic, not auto-immune
NEET 2022 (Q.179) paired "Myasthenia gravis" with "genetic disorder" and "Muscular dystrophy" with "auto-immune" — both wrong, but easy to miss in a 60-second read. The musculo-skeletal features of MG are covered separately under muscular-skeletal disorders; this page treats the immunological mechanism only.
Rule: Myasthenia gravis = antibodies against AChR at the NMJ (auto-immune). Muscular dystrophy = progressive degeneration of skeletal muscle due to genetic defect (not auto-immune).
Other auto-immune diseases NEET expects you to recognise
Beyond NCERT's two named diseases, NEET 2018 already tested four more in a single MCQ — psoriasis, rheumatoid arthritis, vitiligo and Alzheimer's — to check whether students can distinguish auto-immune from non-auto-immune pathology. The list below covers every auto-immune disease that has appeared in NEET MCQs or NCERT/NIOS supplementary text, organised by target tissue. Each card pairs the disease name with the self-antigen attacked — the exam-relevant unit of memory.
Memorise auto-immune diseases by the self-antigen attacked. NEET MCQs almost always test the antigen-to-disease pairing rather than treatment.
Rheumatoid arthritis
Target: synovial membrane of joints
Joint inflammation → pannus → cartilage and bone erosion. Named in NCERT 7.2.6.
Myasthenia gravis
Target: ACh receptors at NMJ
Skeletal muscle fatigue, ptosis, progressive weakness. NEET 2021 Q.160.
Type 1 diabetes mellitus
Target: pancreatic islet β-cells
Insulin deficiency from cytotoxic-T-cell destruction of β-cells; insulin-dependent.
SLE (lupus)
Target: nuclear antigens (dsDNA)
Multi-organ disease — skin (butterfly rash), kidneys, joints, serosae.
Multiple sclerosis
Target: myelin sheath of CNS neurons
Demyelinating plaques → motor, sensory and visual deficits.
Psoriasis & vitiligo
Target: skin (keratinocytes / melanocytes)
Both featured as auto-immune options in NEET 2018 Q.154.
Treatment principle — dampen the immune response
Because the harmful agent in auto-immune disease is the patient's own immune system, no curative therapy yet exists. Management aims to suppress or modulate the misdirected response. Front-line drugs are corticosteroids (broad anti-inflammatory action), disease-modifying anti-rheumatic drugs such as methotrexate (cytotoxic to proliferating lymphocytes), and biologics that neutralise specific cytokines (anti-TNF-α in RA) or deplete B-cells (anti-CD20). For myasthenia gravis, acetylcholinesterase inhibitors are added to prolong the action of the remaining ACh at the NMJ, while immunosuppressants address the underlying antibody production. Type 1 diabetes is managed with exogenous insulin because β-cell loss is permanent.
Where auto-immunity sits among "abnormal" immune responses
NCERT lists three abnormal contexts in which the immune system plays a central role: allergies, auto-immune disease and organ-transplant rejection. NEET regularly tests whether students can distinguish them — every one of these has appeared as a one-mark MCQ. The differentiator is the target of the immune response and the direction of the malfunction: allergy is hyper-response to an external antigen, auto-immunity is response against self, immunodeficiency is loss of response, and graft rejection is a normal response directed at non-self transplanted tissue. The versus card below pins these distinctions side by side.
Auto-immunity
Self
Target antigen
- Trigger: loss of self/non-self discrimination
- Mechanism: auto-antibodies + self-reactive T-cells
- Examples: RA, MG, T1DM, SLE, MS
- Therapy: immunosuppressants
Allergy / Immunodeficiency
Non-self · Absent
Two contrasting abnormalities
- Allergy: exaggerated IgE response to external antigen (pollen, dust)
- Immunodeficiency: decreased or absent response (e.g. AIDS)
- Graft rejection: normal response to non-self transplant
- None is auto-immune — the target is not "self"
≥ 5
PYQs on Auto-Immunity (NEET 2016–2023)
Auto-immunity has been examined in NEET 2016, 2018, 2021 and 2022, with rheumatoid arthritis and myasthenia gravis the most repeated diseases. Memorise the NCERT one-liner verbatim — most of these MCQs are direct paraphrases.
Worked examples
Q. In higher vertebrates the immune system can distinguish self-cells from non-self. If this property is lost due to genetic abnormality and the system attacks self-cells, the condition is termed —
(1) Graft rejection · (2) Auto-immune disease · (3) Active immunity · (4) Allergic response.
A. Option (2). NCERT 7.2.6 defines auto-immune disease in exactly these words — "due to genetic and other unknown reasons, the body attacks self-cells." Graft rejection is a normal response to non-self tissue; active immunity is the protective response generated by the host on antigen exposure; allergic response is hyper-reaction to an external antigen. Only auto-immunity fits "attacks self-cells."
Q. A chronic auto-immune disorder that affects the neuromuscular junction and produces fatigue, weakening and paralysis of skeletal muscle is —
(1) Gout · (2) Arthritis · (3) Muscular dystrophy · (4) Myasthenia gravis.
A. Option (4) — myasthenia gravis. Auto-antibodies block acetylcholine receptors at the post-synaptic membrane of the NMJ, so end-plate depolarisation fails and muscle contraction weakens. Gout is uric-acid crystal deposition; arthritis is the general term for joint inflammation; muscular dystrophy is a genetic (not auto-immune) progressive muscle degeneration.
Q. Which one is NOT an auto-immune disease — psoriasis, rheumatoid arthritis, Alzheimer's disease, vitiligo?
A. Alzheimer's disease. Psoriasis (skin keratinocytes), rheumatoid arthritis (synovium) and vitiligo (melanocytes) all involve immune attack on self-tissue. Alzheimer's is a neurodegenerative disease characterised by extracellular amyloid plaques and intracellular tau tangles — not driven by anti-self adaptive immunity.
Q. Statement I — Auto-immune disorder is a condition where the body's defence mechanism recognises its own cells as foreign. Statement II — Rheumatoid arthritis is a condition where the body does NOT attack self-cells. Choose the correct option.
A. Statement I is correct, Statement II is incorrect. NCERT 7.2.6 says explicitly that rheumatoid arthritis is an auto-immune disease — i.e., the body DOES attack self-cells (synovial membrane). Therefore Statement II inverts the correct relation, and the correct option is "Statement I correct, Statement II incorrect."
Common confusion & NEET traps
Figure 2. Auto-immunity is not a stronger or weaker immune response; it is the same machinery aimed at the wrong target after self/non-self discrimination fails. The endpoint diseases — rheumatoid arthritis, myasthenia gravis, type 1 diabetes, SLE and multiple sclerosis — differ only in which self-antigen the misidentified attack hits.